A detailed history of Nordea Investment Management Ab transactions in Legend Biotech Corp stock. As of the latest transaction made, Nordea Investment Management Ab holds 238,600 shares of LEGN stock, worth $12.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
238,600
Previous 14,987 1492.05%
Holding current value
$12.1 Million
Previous $840,000 1157.98%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$39.5 - $57.22 $8.83 Million - $12.8 Million
223,613 Added 1492.05%
238,600 $10.6 Million
Q1 2024

May 02, 2024

BUY
$55.06 - $69.99 $825,184 - $1.05 Million
14,987 New
14,987 $840,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $8.5B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.